Phathom Pharmaceuticals (PHAT): filings, insider buys & geopolitical news
In the last 30 days, Geopolitics Alpha logged 2 items on Phathom Pharmaceuticals: 0 news stories, 2 SEC filings and 0 fund or insider trade reports. The latest filing was logged 26 Oct 2026: 8-K - Phathom Pharmaceuticals, Inc. (0001783183) (Filer).
Government contracts
No federal prime contract obligations are matched to Phathom Pharmaceuticals in USAspending.gov for the last five years, and no Department of Defense contract announcements name it in the past year. See the largest government contractors.
PHAT share price, last 12 months
Close $5.99 on Oct 27, 2026, -55.7% since Oct 24, 2025 (range $5.72 to $18.08, daily closes).
Company facts
- Ticker
- PHAT (NasdaqGS)
- Sector
- Health
- Industry (SEC SIC code)
- Pharmaceutical Preparations (2834)
Industry from the SEC Standard Industrial Classification code on the company's EDGAR filings.
What changed for Phathom Pharmaceuticals (PHAT)
In the last 30 days, Geopolitics Alpha logged 2 items on Phathom Pharmaceuticals: 0 news stories, 2 SEC filings and 0 fund or insider trade reports. The latest filing was logged 26 Oct 2026: 8-K - Phathom Pharmaceuticals, Inc. (0001783183) (Filer).
- 0 news
- 2 SEC filings
- 0 fund / insider trades
Latest SEC filings
- 8-K - Phathom Pharmaceuticals, Inc. (0001783183) (Filer) 26 Oct 2026
- 8-K - Phathom Pharmaceuticals, Inc. (0001783183) (Filer) 23 Oct 2026
Latest fund & insider buys and sales
None on record yet.
Latest geopolitical & market news
None on record yet.
Peers: Pharmaceutical Preparations
| Company | Ticker | Federal contracts, 12 months |
|---|---|---|
| Eli Lilly and | LLY | – |
| Johnson & Johnson | JNJ | – |
| AbbVie | ABBV | – |
| Merck | MRK | $2.5M |
| Novartis AG | NVS | – |
| AstraZeneca | AZN | – |
| Abbott Laboratories | ABT | $147.5M |
| Novo Nordisk A/S | NVO | – |
| Pfizer | PFE | -$122K |
| Vertex Pharmaceuticals | VRTX | – |
Biggest government contractors in Health: Regeneron Pharmaceuticals ($279.4M), Fresenius Medical Care AG ($236.7M), Emergent BioSolutions ($216.6M), DaVita ($154.5M), Abbott Laboratories ($147.5M), Amgen ($126.0M), Labcorp Holdings ($96.4M), Stryker ($92.5M).
Congressional trades in PHAT
Trades in PHAT that members of Congress have publicly reported, newest filing first.
No congressional trades are stored for this view yet.
All congressional stock trades →
Geopolitical news for PHAT
Everything on PHAT, newest first
- SEC filing 8-K - Phathom Pharmaceuticals, Inc. (0001783183) (Filer)
26 Oct 2026, 10:02 UTC
- SEC filing 8-K - Phathom Pharmaceuticals, Inc. (0001783183) (Filer)
23 Oct 2026, 21:00 UTC
Frequently asked questions
Does Phathom Pharmaceuticals have government contracts?
No federal prime contract obligations are matched to Phathom Pharmaceuticals (PHAT) in USAspending.gov for the last five years. Subcontracts are not included.
Where does the contract data come from?
USAspending.gov (the official source of U.S. federal spending data) and the Department of Defense's daily contract announcements. Both are public domain and refreshed daily here.
What geopolitical news affects PHAT?
This page lists every Geopolitics Alpha note that names PHAT as exposed to an event, with the reason it is exposed.
Has Congress traded PHAT?
The table above lists trades in PHAT that members of Congress have publicly reported, with a link to each official filing.
Is this investment advice?
No. We show news, exposure and past price moves. Nothing here is a recommendation.